Cargando…
Liquid biopsy: a step forward towards precision medicine in urologic malignancies
There is a growing trend towards exploring the use of a minimally invasive “liquid biopsy” to identify biomarkers in a number of cancers, including urologic malignancies. Multiple aspects can be assessed in circulating cell-free DNA, including cell-free DNA levels, integrity, methylation and mutatio...
Autores principales: | Di Meo, Ashley, Bartlett, Jenni, Cheng, Yufeng, Pasic, Maria D., Yousef, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391592/ https://www.ncbi.nlm.nih.gov/pubmed/28410618 http://dx.doi.org/10.1186/s12943-017-0644-5 |
Ejemplares similares
-
Proteomics and peptidomics: moving toward precision medicine in urological malignancies
por: Meo, Ashley Di, et al.
Publicado: (2016) -
Circular RNA in liquid biopsy as biomarkers toward precision medicine
por: Lee, Yueh-Chun, et al.
Publicado: (2023) -
Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma
por: Ferrante, Giuliana, et al.
Publicado: (2022) -
Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
por: Zeng, Chang, et al.
Publicado: (2019) -
“Liquid biopsy” - extracellular vesicles as potential novel players towards precision medicine in asthma
por: Ambrożej, Dominika, et al.
Publicado: (2022)